Abstract
In the United States alone there will be approximately 140 000 cases of lung cancer during 1987. Functionally, these diseases are divided into tumors of the non-small cell (NSCL) and small cell (SCLC) varieties. The former category includes squamous cell adenocarcinoma and large cell anaplastic tumors and the latter includes small cell anaplastic carcinoma, all defined by light microscopy. This functional classification is based upon each category’s distinctive clinical biology, i.e., (a) the potential for surgical curability of NSCL; (b) the propensity of SCLC to widespread dissemination; and (c) the relative responsiveness or unresponsiveness of SCLC and NSCL to existing cytotoxic modalities.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Carney DN, Broder L, Edelstein M et al. (1983) Experimental studies of the biology of human small cell lung cancer. Cancer Treat Rep 67: 27
Mountain CF (1986) A new international staging system for lung cancer. Chest 89: 225S
Greco FA (1986) Rationale for chemotherapy for patients with advanced non-small cell lung cancer. Semin Oncol 13: 92
Comis RL (1987) Chemotherapy of small cell lung cancer. In: DeVita VT, Hellman S, Rosenberg SA (eds) Principles and practice of oncology update, vol 1. Lippincott, Philadelphia, p 7
Perry MC, Eaton WL, Propert KJ et al. (1987) Chemotherapy with or without radiation therapy in limited small cell carcinoma of the lung. N Engl J Med 316: 912
Einhorn L, Greco FA, Cohen H, Birch R (1987) Late consolidation with cisplatin plus VP-16 (PVP16) following induction chemotherapy with cyclophosphamide, adriamycin and vincristine (CAV) in limited small cell lung cancer (SCLC): a Southeastern Cancer Study Group ( SECSG) random prospective study. Proc Am Soc Clin Oncol 6: 166
Feld R, Evans WK, Coy P et al. (1987) Canadian multicenter randomized trial comparing sequential and alternating administration of two noncross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung. J Clin Oncol 5 (9): 1401
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Comis, R.L. (1989). Lung Cancer. In: Magrath, I. (eds) New Directions in Cancer Treatment. UICC International Union Against Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83405-9_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-83405-9_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-19063-9
Online ISBN: 978-3-642-83405-9
eBook Packages: Springer Book Archive